OBJECTIVE: To implement and evaluate a specialized service for type 2 diabetes mellitus in the community pharmacy. DESIGN: Parallel group, multisite, control versus intervention, repeated measures design, with three different regions in New South Wales, Australia, used as intervention regions, then matched with control regions as much as possible. INTERVENTION: Following training, pharmacists followed a clinical protocol over 9 months, with approximately monthly intervention site visits during which blood glucose readings were downloaded and discussed with the patient, interventions were documented, and goals set with each patient. MAIN OUTCOME MEASURES: Quality of life, well-being, risk of nonadherence, and glycosylated hemoglobin (A1C) values at the beginning and end of the study. Blood glucose levels were measured in intervention patients only. RESULTS:A total of 106 intervention and 82 control patients completed the study. Patient groups were similar at baseline. Pharmacists delivered 1,459 interventions and blood glucose levels were significantly reduced in all intervention regions. The proportion of patients with A1C values greater than 7% was similar in control sites at baseline (54%) and after 9 months (61%). In intervention sites this proportion was significantly reduced, from 72% at baseline to 53% after 9 months. Well-being and the risk of nonadherence were significantly improved in intervention patients. CONCLUSION: Implementation of a specialized service for diabetes in community pharmacy resulted in better diabetes control and health care outcomes for the patient.
RCT Entities:
OBJECTIVE: To implement and evaluate a specialized service for type 2 diabetes mellitus in the community pharmacy. DESIGN: Parallel group, multisite, control versus intervention, repeated measures design, with three different regions in New South Wales, Australia, used as intervention regions, then matched with control regions as much as possible. INTERVENTION: Following training, pharmacists followed a clinical protocol over 9 months, with approximately monthly intervention site visits during which blood glucose readings were downloaded and discussed with the patient, interventions were documented, and goals set with each patient. MAIN OUTCOME MEASURES: Quality of life, well-being, risk of nonadherence, and glycosylated hemoglobin (A1C) values at the beginning and end of the study. Blood glucose levels were measured in intervention patients only. RESULTS: A total of 106 intervention and 82 control patients completed the study. Patient groups were similar at baseline. Pharmacists delivered 1,459 interventions and blood glucose levels were significantly reduced in all intervention regions. The proportion of patients with A1C values greater than 7% was similar in control sites at baseline (54%) and after 9 months (61%). In intervention sites this proportion was significantly reduced, from 72% at baseline to 53% after 9 months. Well-being and the risk of nonadherence were significantly improved in intervention patients. CONCLUSION: Implementation of a specialized service for diabetes in community pharmacy resulted in better diabetes control and health care outcomes for the patient.
Authors: Zheng Kang Lum; Melanie Yee Lee Siaw; Michelle Jia Xin Lee; Zexuan Koh; Parry Quan Zhang; Soo Kiang Eng; Swee Chin Tan; Joyce Yu-Chia Lee Journal: Qual Life Res Date: 2019-07-29 Impact factor: 4.147
Authors: Els Mehuys; Leen De Bolle; Luc Van Bortel; Lieven Annemans; Inge Van Tongelen; Jean-Paul Remon; Mimi Giri Journal: Pharm World Sci Date: 2007-06-23
Authors: Liz Steed; Ratna Sohanpal; Adam Todd; Vichithranie W Madurasinghe; Carol Rivas; Elizabeth A Edwards; Carolyn D Summerbell; Stephanie Jc Taylor; R T Walton Journal: Cochrane Database Syst Rev Date: 2019-12-06